Acadia Healthcare's (ACHC) stock plummeted by a staggering 22.39% in pre-market trading on Friday, following the release of disappointing fourth-quarter 2024 financial results and a lacklustre full-year 2025 guidance.
The leading provider of behavioral healthcare services reported revenue of $774.2 million for the fourth quarter, missing the consensus estimate of $779 million. Additionally, the company's adjusted EBITDA of $153.1 million fell short of the expected $171.4 million, despite posting a net income of $33.5 million for the quarter.
Looking ahead, Acadia's full-year 2025 guidance further dampened investor sentiment. The company forecasted revenue in the range of $3.3 billion to $3.4 billion and adjusted EBITDA between $675 million and $725 million, both falling below analysts' expectations. Acadia also anticipated capital expenditures ranging from $525 million to $575 million as it continues to invest in expanding its psychiatric bed capacity to meet the growing demand for mental health services.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.